|
1
|
Randers E and Erlandsen EJ: Serum cystatin
C as an endogenous marker of the renal function - a review. Clin
Chem Lab Med. 37:389–395. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Finney H, Bates CJ and Price CP: Plasma
cystatin C determinations in healthy elderly population. Arch
Gerontol Geriatr. 29:75–94. 1999. View Article : Google Scholar
|
|
3
|
Fliser D and Ritz E: Serum cystatin C
concentration as a marker of renal dysfunction in the elderly. Am J
Kidney Dis. 37:79–83. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldberg TH and Finkelstein MS:
Difficulties in estimating glomerular filtration rate in the
elderly. Arch Intern Med. 147:1430–1433. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Friedman JR, Norman DC and Yoshikawa TT:
Correlation of estimated renal function parameters versus 24-hour
creatinine clearance in ambulatory elderly. J Am Geriatr Soc.
37:145–149. 1989.PubMed/NCBI
|
|
6
|
Van Pottelbergh G, Van Heden L, Matheï C
and Degryse J: Methods to evaluate renal function in elderly
patients: a systematic literature review. Age Ageing. 39:542–548.
2010.PubMed/NCBI
|
|
7
|
Simonsen O, Grubb A and Thysell H: The
blood serum concentration of cystatin C (c trace) as a measure of
the glomerular filtration rate. Scand J Clin Lab Invest. 45:97–101.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grubb A, Simonsen O, Sturtfelt G, Truedson
L and Thysell H: Serum concentration of cystatin C, factor D and
β2-microglobulin as a measure of glomerular filtration rate. Acta
Med Scand. 218:499–503. 1985.PubMed/NCBI
|
|
9
|
Keller CR, Odden MC, Fried LF, et al:
Kidney function and markers of inflammation in elderly persons
without chronic kidney disease: the health, aging, and body
composition study. Kidney Int. 71:239–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Singh D, Whooley MA, Ix JH, Ali S and
Shlipak MG: Association of cystatin C and estimated GFR with
inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial
Transplant. 22:1087–1092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kos J, Krasovec M, Cimerman N, Nielsen HJ,
Christensen IJ and Brünner N: Cysteine proteinase inhibitors stefin
A, stefin B, and cystatin C in sera from patients with colorectal
cancer: relation to prognosis. Clin Cancer Res. 6:505–511.
2000.PubMed/NCBI
|
|
12
|
Kos J, Stabuc B, Schweigen A, et al:
Cathepsins B, H, and L and their inhibitors stefin A and cystatin C
in sera of melanoma patients. Clin Cancer Res. 3:1815–1822.
1997.PubMed/NCBI
|
|
13
|
Bodnar L, Wcislo GB, Smoter M, et al:
Cystatin C as a parameter of glomerular filtration rate in patients
with ovarian cancer. Kidney Blood Press Res. 33:360–367. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Newman DJ, Thakkar H, Edwards RG, et al:
Serum cystatin C measured by automated immunoassay: a more
sensitive marker of changes in GFR than serum creatinine. Kidney
Int. 47:312–318. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stabuc B, Vrhovec L, Stabuc-Silih M and
Cizej TE: Improved prediction of decreased creatinine clearance by
serum cystatin C: use in cancer patients before and during
chemotherapy. Clin Chem. 46:193–197. 2000.PubMed/NCBI
|
|
16
|
Naumnik W, Niklińska W, Ossolińska M and
Chyczewska E: Serum cathepsin K and cystatin C concentration in
patients with advanced non-small-cell lung cancer during
chemotherapy. Folia Histochem Cytobiol. 47:207–213. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lababede O, Meziane M and Rice T: Seventh
edition of the cancer staging manual and stage grouping of lung
cancer: quick reference chart and diagrams. Chest. 139:183–189.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Satoh H, Kurishima K, Nakamura R, et al:
Lung cancer in patients aged 80 years and over. Lung Cancer.
65:112–118. 2009.PubMed/NCBI
|
|
19
|
Tanaka M, Matsuo K, Enomoto M and Mizuno
K: A sol particle homogeneous immunoassay for measuring serum
cystatin C. Clin Biochem. 37:27–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Coll E, Botey A, Alvarez L, et al: Serum
cystatin C as a new marker for noninvasive measurement of
glomerular filtration rate and as a marker for early renal
impairment. Am J Kidney Dis. 36:29–34. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ognibene A, Mannucci E, Caldini A, et al:
Cystatin C reference values and aging. Clin Biochem. 39:658–661.
2006. View Article : Google Scholar
|
|
22
|
Van Den Noortgate NJ, Janssens WH,
Delanghe JR, Afschrift MB and Lameire NH: Serum cystatin C
concentration compared with other markers of glomerular filtration
rate in the old old. J Am Geriatr Soc. 50:1278–1282.
2002.PubMed/NCBI
|
|
23
|
Reed CH: Diagnostic applications of
cystatin C. Br J Biomed Sci. 57:323–329. 2000.PubMed/NCBI
|
|
24
|
Curhan G: Cystatin C: a marker of renal
function or something more. Clin Chem. 51:293–294. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Knight EL, Verhave JC, Spiegelman D, et
al: Factors influencing serum cystatin C levels other than renal
function and the impact on renal function measurement. Kidney Int.
65:1416–1421. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grubb A, Björk J, Nyman U, et al: Cystatin
C, a marker for successful aging and glomerular filtration rate, is
not influenced by inflammation. Scand J Clin Lab Invest.
71:145–149. 2011.PubMed/NCBI
|
|
27
|
Sloane BF: Suicidal tumor proteases. Nat
Biotechnol. 14:826–827. 1996. View Article : Google Scholar : PubMed/NCBI
|
